Former Boston Scientific Assets Relaunched
Navilyst Medical is the newest player on the healthcare market that specializes in the development of tools for fluid management and vascular access. The company’s launch was described in the Boston Herald.
The organization is a combination of the two former Boston Scientific subsidiaries which were purchased by Avista Capital Partners. That sale was previously described on HospitalBuyer.
The new company is specializing in the development of catheters and valves intended to reduce the incidence of complications, specifically bloodstream infections associated with implanted catheters. Procedures that frequently use such devices include angioplasty and angiography.
Some of the company’s other products, many of which are well recognized, include PASV Valve Technology, NAMIC Fluid Management devices, and Xcela PICC. The NAMIC line of products already has a significant share of the global marketplace.
The new President is Dave McCellan, who had been running the oncology business for Boston Scientific. The new Chief Executive at Navilyst is Rob Sparks, who served as a healthcare adviser for Avista.
August 6, 2008 Related topics: Partnerships & Consortia, Mergers & Acquisitions